{ "format" : "linked-data-api", "version" : "0.2", "result" : {"_about" : "http://eldaddp.azurewebsites.net/answeredquestions.text?answer.questionFirstAnswered.=2016-10-20T08%3A44%3A16.88Z&max-ddpModified.=2016-10-20T09%3A16%3A05.534Z", "definition" : "http://eldaddp.azurewebsites.net/meta/answeredquestions.text?answer.questionFirstAnswered.=2016-10-20T08%3A44%3A16.88Z&max-ddpModified.=2016-10-20T09%3A16%3A05.534Z", "extendedMetadataVersion" : "http://eldaddp.azurewebsites.net/answeredquestions.text?answer.questionFirstAnswered.=2016-10-20T08%3A44%3A16.88Z&max-ddpModified.=2016-10-20T09%3A16%3A05.534Z&_metadata=all", "first" : "http://eldaddp.azurewebsites.net/answeredquestions.text?answer.questionFirstAnswered.=2016-10-20T08%3A44%3A16.88Z&_page=0&max-ddpModified.=2016-10-20T09%3A16%3A05.534Z", "hasPart" : "http://eldaddp.azurewebsites.net/answeredquestions.text?answer.questionFirstAnswered.=2016-10-20T08%3A44%3A16.88Z&max-ddpModified.=2016-10-20T09%3A16%3A05.534Z", "isPartOf" : "http://eldaddp.azurewebsites.net/answeredquestions.text?answer.questionFirstAnswered.=2016-10-20T08%3A44%3A16.88Z&max-ddpModified.=2016-10-20T09%3A16%3A05.534Z", "items" : [{"_about" : "http://data.parliament.uk/resources/601096", "AnsweringBody" : [{"_value" : "Department of Health"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/601096/answer", "answerText" : {"_value" : "
The Department has received a small number of letters about the availability of injectable B12 over the counter and the issue was also raised at a meeting between the B12 Deficiency Group and the then Parliamentary Under-Secretary of State for Public Health (Jane Ellison) in July 2016. All authorised medicines for injection are classified by the Medicines and Healthcare products Regulatory Agency as prescription only. Whether or not a patient could self-administer a prescribed medicine would be a matter of clinical judgement for the patient\u2019s doctor to determine.<\/p>
The diagnosis and treatment for B12 deficiencies is well established and reported in the British Committee for Standards in Haematology (BCSH) guidance document, Guidelines for the diagnosis and treatment of Cobalamin and Folate disorders<\/em>. The guidance was last updated in May 2014 and can be found at the following link:<\/p>